Evaluating vaccines and treatments for various infections and diseases.
University of Washington Vaccine and Treatment Evaluation Unit
The University of Washington is running friendly studies to test new vaccines and treatments for infections like colds, STIs, and malaria, and they invite patients to join in and help improve medical care for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10987042 on NIH RePORTER |
What this research studies
The University of Washington Vaccine and Treatment Evaluation Unit (VTEU) focuses on conducting clinical trials to evaluate vaccines and treatments for a range of infectious diseases, including respiratory infections, sexually transmitted infections, and malaria. Led by experienced investigators, the VTEU collaborates with local and international experts to ensure comprehensive research methodologies. Patients may participate in trials that assess the safety and effectiveness of new treatments, contributing to advancements in medical care. The unit is well-equipped with facilities designed specifically for clinical trials, ensuring a supportive environment for participants.
Who could benefit from this research
Good fit: Ideal candidates include children and adults who are at risk for or affected by the targeted infectious diseases being studied.
Not a fit: Patients with conditions unrelated to the infectious diseases under investigation may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and treatments for infectious diseases, enhancing patient health outcomes.
How similar studies have performed: Previous research in similar areas has shown success in developing effective vaccines and treatments, indicating a promising potential for this initiative.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Wald, Anna — University of Washington
- Study coordinator: Wald, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.